Cisatracurium is a non-depolarising neuromuscular blocking agent of the benzylisoquinolinium class, available in its salt form, cisatracurium besylate. Cisatracurium has an intermediate duration of action and is one of the most commonly used neuromuscular blocking agents in intensive care.. Cisatracurium acts on cholinergic receptors, blocking neuromuscular ...
Cisatracurium is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and pediatric patients 1 month to 12 years of age. Cisatracurium is also indicated to provide skeletal muscle relaxation during surgery in adults and pediatric patients 2 to 12 years of age as a bolus or infusion maintenance and for mechanical ventilati...
Zhongda Hospital, Affiliated to Southeast University, Nanjing, Jiangsu, China
Siriraj Hospital, Bangkok, Thailand
the Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, China
Linkup Chang Gung Memorial Hospital, Taoyuan City, Taiwan
Rigshospitalet, Copenhagen, Denmark
Universidade Federal de Minas Gerais, Faculdade de Medicina, Departamento de Cirurgia., Belo Horizonte, Minas Gerais, Brazil
Ain Shams University hospitals, Cairo, Egypt
Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand
Herlev Hospital, Herlev, Denmark
Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.